This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mebatsion, T. Articles by Conzelmann, K. K. Search for Related Content PubMed PubMed Citation Articles by Mebatsion, T. Articles by Conzelmann, K. K.

 Previous Article  |  Next Article 

J. Virol., Mar 1995, 1444-1451, Vol 69, No. 3
Copyright © 1995, American Society for Microbiology

Mokola virus glycoprotein and chimeric proteins can replace rabies virus glycoprotein in the rescue of infectious defective rabies virus particles

T Mebatsion, MJ Schnell and KK Conzelmann
Federal Research Centre for Virus Diseases of Animals, Tubingen, Germany.

A reverse genetics approach which allows the generation of infectious defective rabies virus (RV) particles entirely from plasmid-encoded genomes and proteins (K.-K. Conzelmann and M. Schnell, J. Virol. 68:713- 719, 1994) was used to investigate the ability of a heterologous lyssavirus glycoprotein (G) and chimeric G constructs to function in the formation of infectious RV-like particles. Virions containing a chloramphenicol acetyltransferase (CAT) reporter gene (SDI-CAT) were generated in cells simultaneously expressing the genomic RNA analog, the RV N, P, M, and L proteins, and engineered G constructs from transfected plasmids. The infectivity of particles was determined by a CAT assay after passage to helper virus-infected cells. The heterologous G protein from Eth-16 virus (Mokola virus, lyssavirus serotype 3) as well as a construct in which the ectodomain of RV G was fused to the cytoplasmic and transmembrane domains of the Eth-16 virus G rescued infectious SDI-CAT particles. In contrast, a chimeric protein composed of the amino-terminal half of the Eth-16 virus G and the carboxy-terminal half of RV G failed to produce infectious particles. Site-directed mutagenesis was used to convert the antigenic site III of RV G to the corresponding sequence of Eth-16 G. This chimeric protein rescued infectious SDI-CAT particles as efficiently as RV G. Virions containing the chimeric protein were specifically neutralized by an anti-Eth-16 virus serum and escaped neutralization by a monoclonal antibody directed against RV antigenic site III. The results show that entire structural domains as well as short surface epitopes of lyssavirus G proteins may be exchanged without affecting the structure required to mediate infection of cells.

This article has been cited by other articles:

• Guyatt, K. J., Twin, J., Davis, P., Holmes, E. C., Smith, G. A., Smith, I. L., Mackenzie, J. S., Young, P. L. (2003). A molecular epidemiological study of Australian bat lyssavirus. J. Gen. Virol. 84: 485-496 [Abstract] [Full Text]  
• Biacchesi, S., Bearzotti, M., Bouguyon, E., Bremont, M. (2002). Heterologous Exchanges of the Glycoprotein and the Matrix Protein in a Novirhabdovirus. J. Virol. 76: 2881-2889 [Abstract] [Full Text]  
• Foley, H. D., McGettigan, J. P., Siler, C. A., Dietzschold, B., Schnell, M. J. (2000). A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection. Proc. Natl. Acad. Sci. USA 10.1073/pnas.011510698v1 [Abstract] [Full Text]  
• Tao, T., Skiadopoulos, M. H., Davoodi, F., Riggs, J. M., Collins, P. L., Murphy, B. R. (2000). Replacement of the Ectodomains of the Hemagglutinin-Neuraminidase and Fusion Glycoproteins of Recombinant Parainfluenza Virus Type 3 (PIV3) with Their Counterparts from PIV2 Yields Attenuated PIV2 Vaccine Candidates. J. Virol. 74: 6448-6458 [Abstract] [Full Text]  
• Jallet, C., Jacob, Y., Bahloul, C., Drings, A., Desmezieres, E., Tordo, N., Perrin, P. (1999). Chimeric Lyssavirus Glycoproteins with Increased Immunological Potential. J. Virol. 73: 225-233 [Abstract] [Full Text]  
• Mochizuki, H., Schwartz, J. P., Tanaka, K., Brady, R. O., Reiser, J. (1998). High-Titer Human Immunodeficiency Virus Type 1-Based Vector Systems for Gene Delivery into Nondividing Cells. J. Virol. 72: 8873-8883 [Abstract] [Full Text]  
• Foley, H. D., McGettigan, J. P., Siler, C. A., Dietzschold, B., Schnell, M. J. (2000). A recombinant rabies virus expressing vesicular stomatitis virus glycoprotein fails to protect against rabies virus infection. Proc. Natl. Acad. Sci. USA 97: 14680-14685 [Abstract] [Full Text]